PHOENIX, Ariz. May 4, 2009 Today's opening of a new breast health center next to John C. Lincoln Deer Valley Hospital will provide significant research opportunities for the Translational Genomics Research Institute (TGen).
The 9,000-square-foot Breast Health and Research Center will include a tumor biorepository for TGen that will aid the non-profit research institute in discovering new ways to diagnose and treat breast cancer, which affects 1 in every 8 American women.
"What this partnership means is that breast cancer research at TGen will be significantly accelerated, specifically in development of more accurate diagnostic tests and smarter treatment options for newly-diagnosed breast cancer patients,'' said Dr. Heather Cunliffe, head of TGen's Breast & Ovarian Cancer Research Unit.
The new center is located in John C. Lincoln's Medical Offices 3, 19646 N. 27th Ave., just southwest of Interstate 17 and Loop 101, in northwest Phoenix.
"Our new state-of-the-art medical equipment allows the earliest possible detection of breast cancers when survival rates are highest and treatment is less invasive," said Sherry Gage, Clinical Director of John C. Lincoln's new center.
"But, our staff also knows the key component of the care they offer is their personalized and genuine concern for their patients. We're not just here to give the diagnosis, we're here to help patients at all stages," said Gage, a Registered Radiologic Technologist.
Breast cancer patients at the new center who agree to donate their tumor tissues will boost TGen's abilities to use genomic and proteomic research toward development of new ways to combat breast cancer.
TGen's role at the new center will be for research; not for TGen clinical trials.
"We are thrilled that JCL and TGen have developed a strong strategic partnership to benefit breast cancer patients,'' said Dr. Cunliffe, who also is an Investigator in TGen's Computational Biology Division.
The new center provides TGen with yet another avenue of assisting local hospital and research networks, including Arizona's three major universities, St. Joseph's Hospital and Medical Center, Banner Health and Scottsdale Healthcare.
"This is another example of how Arizona is forging new ground through fostering broadly the alignment of clinical centers of excellence, such as John C. Lincoln, with biomedical research organizations, such as TGen. The ultimate beneficiaries are of course our patients who have cancer and other debilitating diseases," said Dr. Jeffrey Trent, TGen's President and Research Director.
|Contact: Steve Yozwiak, TGen Senior Science Writer|
The Translational Genomics Research Institute